New Pathways in Atopic Dermatitis
After a 15-year drought of new therapies for atopic dermatitis (AD), a deeper understanding of the underlying pathophysiology of the disease has heralded an effective new armamentarium of approved and emerging immunomodulatory agents. These agents offer new hope to patients and families who suffer from the impact of AD, including intractable pruritus, skin manifestations, and diminished quality of life. In this three-module eCourse, two expert faculty describe the value of these new agents and how to incorporate them into your own practice to improve patient care.
Audio-enhanced slide lectures
Release Date: November 30, 2017
Expiration Date: November 30, 2018